OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Endocrinology Diabetes and Obesity is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	40
Updates in thyroid healthcare delivery: advancing patient-centered care	34
Obesity and infertility: a double whammy	34
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	33
Advances in assessment and treatment of bone, mineral and parathyroid disorders	32
Editorial introduction	28
Nutrition and thyroid disease	28
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	28
Beyond weight loss: tirzepatide as a dual GIP/GLP-1 receptor agonist for obstructive sleep apnea	26
Editorial introduction	26
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	24
Recent advances in anaplastic thyroid cancer management	20
Financial toxicity in thyroid cancer survivors	20
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	20
An update on bone in diabetes	20
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency	19
Preventing type 1 diabetes development and preserving beta-cell function	19
Editorial introduction	17
Update on fracture risk assessment in osteoporosis	16
The use of anabolic agents in the treatment of osteoporosis: a clinical update	16
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	14
Gastrointestinal hormones and regulation of gastric emptying	14
Interactions between antidiabetes medications and heart–brain axis	14
Fibrous dysplasia in children and its management	13
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	13

Epidemiologic changes in thyroid disease	12
Assisted reproductive technology outcomes and management considerations for people with epilepsy	12
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	12
Precision medicine in diabetes care	12
Long-acting amylin analogues for the management of obesity	12
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	12
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	11
Type 2 diabetes: a contemporary view from the Asian lens	11
A short history of saturated fat: the making and unmaking of a scientific consensus	11
Editorial introductions	11
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	11
The uncommon forms of congenital adrenal hyperplasia	11
An update on investigation and management of renal bone disease	10
Editorial introductions	10
Adrenal insufficiency and pregnancy	10
Novel techniques for assessment of bone tissue material properties	10
Glucocorticoid withdrawal syndrome: what to expect and how to manage	10
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation	10
Legislation, medicine, and politics: care for gender diverse youth	10
Editorial introductions	9
Time to cycle regularity and health risks	9
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	9
Editorial introductions	9
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective	8
The interaction between gut microbiome and bone health	8
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	8
Indications for testosterone therapy in men	8
Microplastics, cardiometabolic risk, genetics and Alzheimer's disease	8
Multifactorial chylomicronemia syndrome	8
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome	7
Advanced imaging and theranostics in thyroid cancer	7
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?	7
Type 2 diabetes mellitus and cognitive function: understanding the connections	7
The psychosocial impact of thyroid cancer	7
Polygenic risk scores for the diagnosis and management of dyslipidemia	7